Added value of 99mTc-HMPAO-labeled leukocyte SPECT/ CT in the characterization and management of patients with infectious endocarditis

Journal of Nuclear Medicine

Volumn 53, Issue 8, 2012, Pages 1235-1243

  Erba, Paola A ^a   Conti, Umberto ^b   Lazzeri, Elena ^a   Sollini, Martina ^a   Doria, Roberta ^b   De Tommasi, Salvatore M ^b   Bandera, Francesco ^c   Tascini, Carlo ^b   Menichetti, Francesco ^b   Dierckx, Rudi A J O ^d   Signore, Alberto ^d,e   Mariani, Giuliano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c IRCCS POLICLINICO SAN DONATO   (Italy)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

99mtc hmpao wbc; Infectious endocarditis

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; HEART SCINTISCANNING; HEART SURGERY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOACTIVITY; SEPTIC EMBOLISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BLOOD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ELECTROCARDIOGRAPHY; ENDOCARDITIS; INFECTION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING;

ELECTROCARDIOGRAPHY; ENDOCARDITIS; FEMALE; HUMANS; INFECTION; LEUKOCYTES; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; TECHNETIUM TC 99M EXAMETAZIME;

EID: 84864739154     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.099424     Document Type: Article

References (38)

1. Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted Country, Minnesota. JAMA. 2005;293:3022-3028. (Pubitemid 40965072)
2. Durante-Mangoni E, Bradley S, Selton-Suty C, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168:2095-2103.
3. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998;98:2936-2948. (Pubitemid 29003982)
4. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke endocarditis service. Am J Med. 1994;96:200-209.
5. Habib G, Derumeaux G, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33: 2023-2029.
6. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
7. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-2413.
8. Cahn-Hidalgo DG, Cappuccio JD. Infective endocarditis. In: Black ER, ed. Diagnostic Strategies for Common Medical Problems. East Pretoria, IL: Versa Press Inc.; 1999:280-290.
9. Chelazzi C, Selmi V, Vitali L, De Gaudio AR. Infections of cardiac implantable electronic devices: etiology, prevention and treatment. In: Vonend O, Eckert S, eds. Aspects of Pacemakers: Functions and Interactions in Cardiac and Non- Cardiac Indications. Rijeka, Croatia: InTech; 2011:127-141.
10. Raoult D, Casalta JP, Richet H, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43:5238-5242. (Pubitemid 41484031)
11. Roca M, Martín-Comín J, Becker W, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Eur J Nucl Med. 1998;25:797-799. (Pubitemid 28377045)
12. 99mTc-HMPAO: Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842-848.
13. 99mTc-Exametazime (HMPAO)-Labeled Leukocyte Scintigraphy for Suspected Infection/Inflammation, version 3.0, approved June 2, 2004. Available at: http://interactive.snm.org/docs/HMPAO-v3.pdf. Accessed June 19, 2012.
14. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Disease Society of America. Circulation. 2005;111:e394-e434.
15. Vilacosta I, Graupner C, San Roman JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol. 2002;39:1489-1495. (Pubitemid 34439065)
16. Evangelista A, Gonzalez-Alujas MT. Echocardiography in infective endocarditis. Heart. 2004;90:614-617. (Pubitemid 38668527)
17. Hill EE, Herijgers P, Claus P, Vanderschueren S, Peetermans WE, Herregods MC. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J. 2007;154:923-928. (Pubitemid 350001280)
18. Murphy JG, Foster-Smith K. Management of complications of infective endocarditis with emphasis on echocardiographic findings. Infect Dis Clin North Am. 1993;7:153-165.
19. Habib G, Badano L, Tribouilloy C, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010;11:202-219.
20. Di Salvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol. 2001;37:1069-1076. (Pubitemid 32217608)
21. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14:177-207. (Pubitemid 32096213)
22. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003;89:258-262. (Pubitemid 36241531)
23. Ingui CJ, Shah NP, Oates ME. Infection scintigraphy: added value of single-photon emission computed tomography/computed tomography fusion compared with traditional analysis. J Comput Assist Tomogr. 2007;31:375-380. (Pubitemid 46849904)
24. Cheung GY, Rigby K, Wang R, et al. Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS Pathog. 2010;6:e1001133.
25. Thurlow LR, Thomas VC, Narayanan S, et al. Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect Immun. 2010;78:4936-4943.
26. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Technol. 2004;32:47-57. (Pubitemid 47618976)
27. Vind SH, Hess S. Possible role of PET/CT in infective endocarditis. J Nucl Cardiol. 2010;17:516-519.
28. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in a patient with occult infection. Kaohsiung J Med Sci. 2011;27:528-531.
29. Bertagna F, Bisleri G, Motta F, et al. Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging. November 26, 2011 [Epub ahead of print].
30. 18F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging. 2010;37:1189-1197.
31. 18F FDG uptake at oncologic PET/CT. Radiographics. 2011;31:1287-1305.
32. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
33. 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study. Nucl Med Commun. 2009;30:287-291.
34. 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46:917-922.
35. Kaderli AA, Baran I, Aydin O, et al. Diffuse involvement of the heart and great vessels in primary cardiac lymphoma. Eur J Echocardiogr. 2010;11: 74-76.
36. García JR, Simo M, Huguet M, Ysamat M, Lomeña F. Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma. Clin Transl Oncol. 2006;8:124-128.
37. Abidov A, D'agnolo A, Hayes SW, Berman DS, Waxman AD. Uptake of FDG in the area of a recently implanted bioprosthetic mitral valve [abstract]. Clin Nucl Med. 2004;29:848. (Pubitemid 39557574)
38. 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med. 2006;47:625-632.